Safety and Efficacy of Holmium Laser Enucleation of the Prostate Within Two Weeks of Transrectal Ultrasound‐Guided Prostate Biopsy
ANZ Journal of Surgery · 2026
DOI: 10.1111/ans.70680 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2026. Verfasst von Yi Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Lasers, Solid-State, Prostate, Image-Guided Biopsy. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation Public Welfare Projects of China.
Abstract (Originalsprache)
Backgrounds To evaluate the safety and efficacy of Holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia when performed within 2 weeks after a transrectal prostate biopsy (PB).
Methods
A retrospective study was conducted on 153 patients undergoing HoLEP between March 2020 and April 2023. The cohort was divided into two groups based on the interval between PB and HoLEP: 67 patients underwent HoLEP within 2 weeks post‐PB, and 86 patients underwent HoLEP more than 2 weeks post‐PB. Baseline characteristics and perioperative parameters were documented, including enucleation efficiency (EE), catheter time, hospital stay, and hemoglobin reduction. All patients were followed up at 1, 6, and 12 months postoperatively, with assessments of maximum urinary flow rate ( Q max ), postvoid residual volume (PVR), International Prostate Symptom Score (IPSS), and quality of life (QoL) score. Perioperative and postoperative complication rates were recorded. Spearman's correlation analysis was applied to explore the relationship between the PB‐to‐HoLEP interval and both perioperative parameters and functional outcomes.
Results
Baseline parameters were comparable between groups. No significant differences were observed in perioperative parameters or complication rates between groups. Postoperative outcomes ( Q max , PVR, IPSS, QoL score) in both groups showed significant improvements compared to baseline values; however, these improvements did not differ significantly between groups. Spearman's correlation analysis revealed no significant association between the PB‐to‐HoLEP interval and perioperative parameters, nor with postoperative changes in functional outcomes (delta IPSS, delta Q max , delta PVR).
Conclusion
HoLEP within 2 weeks of transrectal PB does not adversely affect surgical safety or outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
- Department of Urology, Longquan People's Hospital, Lishui, People's Republic of China.
ORCID-Profile: Huifeng Wu
Förderung
- Zhejiang Provincial Natural Science Foundation Public Welfare Projects of China
Zitieren
APA
Zheng, Y., Ye, D., Zhang, N., & Wu, H. (2026). Safety and Efficacy of Holmium Laser Enucleation of the Prostate Within Two Weeks of Transrectal Ultrasound‐Guided Prostate Biopsy. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70680
Vancouver
Zheng Y, Ye D, Zhang N, Wu H. Safety and Efficacy of Holmium Laser Enucleation of the Prostate Within Two Weeks of Transrectal Ultrasound‐Guided Prostate Biopsy. ANZ Journal of Surgery. 2026. doi:10.1111/ans.70680
BibTeX
@article{Zheng2026,
author = {Zheng, Yi and Ye, Dong and Zhang, Nan and Wu, Huifeng},
title = {Safety and Efficacy of Holmium Laser Enucleation of the Prostate Within Two Weeks of Transrectal Ultrasound‐Guided Prostate Biopsy},
journal = {ANZ Journal of Surgery},
year = {2026},
doi = {10.1111/ans.70680}
}
EUVIMED